Quantitative relationship between histamine and 35S release from isolated rat mast cells due to the beta-adrenoceptor blocking drug Kö 1124.

[1]  B. Lemmer,et al.  Membrane effects of beta-adrenergic blocking agents: investigations with the fluorescence probe 1-anilino-8-naphthalene sulfonate (ANS) and antihemolytic activities. , 1973, Biochemical pharmacology.

[2]  B. Uvnäs,et al.  Storage of 5-hydroxytryptamine in rat mast cells. Evidence for an ionic binding to carboxyl groups in a granule heparin-protein complex. , 1972, Acta physiologica Scandinavica.

[3]  A. Langslet.  Membrane stabilization and cardiac effects of d,1-propranolol, d-propranolol and chlorpromazine. , 1970, European journal of pharmacology.

[4]  B. Uvnäs,et al.  Quantitative correlation between degranulation and histamine release following exposure of rat mast cells to compound 48-80 in vitro. , 1970, Acta physiologica Scandinavica.

[5]  G. Fillion,et al.  The release of histamine, heparin and granule protein from rat mast cells treated with compound 48-80 in vitro. , 1970, Acta physiologica Scandinavica.

[6]  B. Uvnäs,et al.  Degranulation and histamine release, two consecutive steps in the response of rat mast cells to compound 48-80. , 1967, Acta physiologica Scandinavica.

[7]  B. Westerholm,et al.  Release of 5‐Hydroxytryptamine and Histamine from Rat Mast Cells1 , 1962 .

[8]  B. Uvnas,et al.  Evidence for energy-requiring processes in histamine release and mast cell degranulation in rat tissues induced by compound 48/80. , 1961, Acta physiologica Scandinavica.

[9]  P. A. Shore,et al.  A method for the fluorometric assay of histamine in tissues. , 1959, The Journal of pharmacology and experimental therapeutics.